nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—MAP1A—hindbrain—amyotrophic lateral sclerosis	0.0435	0.108	CbGeAlD
Estramustine—Gastrointestinal tract irritation—Riluzole—amyotrophic lateral sclerosis	0.0418	0.123	CcSEcCtD
Estramustine—MAP2—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.0373	0.145	CbGpPWpGaD
Estramustine—MAP2—nerve—amyotrophic lateral sclerosis	0.033	0.0819	CbGeAlD
Estramustine—MAP1A—embryo—amyotrophic lateral sclerosis	0.0272	0.0675	CbGeAlD
Estramustine—MAP1A—brainstem—amyotrophic lateral sclerosis	0.0249	0.0618	CbGeAlD
Estramustine—MAP2—hindbrain—amyotrophic lateral sclerosis	0.0247	0.0613	CbGeAlD
Estramustine—Embolism—Riluzole—amyotrophic lateral sclerosis	0.0233	0.0685	CcSEcCtD
Estramustine—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.0215	0.0633	CcSEcCtD
Estramustine—MAP1A—medulla oblongata—amyotrophic lateral sclerosis	0.0174	0.0431	CbGeAlD
Estramustine—ESR2—hindbrain—amyotrophic lateral sclerosis	0.016	0.0397	CbGeAlD
Estramustine—MAP1A—spinal cord—amyotrophic lateral sclerosis	0.0155	0.0385	CbGeAlD
Estramustine—MAP2—embryo—amyotrophic lateral sclerosis	0.0155	0.0383	CbGeAlD
Estramustine—MAP2—LKB1 signaling events—MAPT—amyotrophic lateral sclerosis	0.0153	0.0592	CbGpPWpGaD
Estramustine—MAP2—brainstem—amyotrophic lateral sclerosis	0.0142	0.0351	CbGeAlD
Estramustine—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0404	CcSEcCtD
Estramustine—MAP1A—nervous system—amyotrophic lateral sclerosis	0.0131	0.0324	CbGeAlD
Estramustine—MAP1A—central nervous system—amyotrophic lateral sclerosis	0.0126	0.0312	CbGeAlD
Estramustine—MAP1A—cerebellum—amyotrophic lateral sclerosis	0.0123	0.0305	CbGeAlD
Estramustine—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0352	CcSEcCtD
Estramustine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0344	CcSEcCtD
Estramustine—Thirst—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0335	CcSEcCtD
Estramustine—ESR1—hindbrain—amyotrophic lateral sclerosis	0.011	0.0272	CbGeAlD
Estramustine—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0319	CcSEcCtD
Estramustine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0317	CcSEcCtD
Estramustine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0314	CcSEcCtD
Estramustine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0304	CcSEcCtD
Estramustine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0302	CcSEcCtD
Estramustine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.01	0.0295	CcSEcCtD
Estramustine—MAP1A—brain—amyotrophic lateral sclerosis	0.00998	0.0248	CbGeAlD
Estramustine—MAP2—medulla oblongata—amyotrophic lateral sclerosis	0.00988	0.0245	CbGeAlD
Estramustine—MAP2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00976	0.0379	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.0097	0.0377	CbGpPWpGaD
Estramustine—ESR2—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.00944	0.0367	CbGpPWpGaD
Estramustine—ESR2—brainstem—amyotrophic lateral sclerosis	0.00918	0.0228	CbGeAlD
Estramustine—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00898	0.0265	CcSEcCtD
Estramustine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00889	0.0262	CcSEcCtD
Estramustine—MAP2—spinal cord—amyotrophic lateral sclerosis	0.00881	0.0219	CbGeAlD
Estramustine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00862	0.0254	CcSEcCtD
Estramustine—Depression—Riluzole—amyotrophic lateral sclerosis	0.00833	0.0245	CcSEcCtD
Estramustine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00823	0.0243	CcSEcCtD
Estramustine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00818	0.0241	CcSEcCtD
Estramustine—ESR2—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.00746	0.029	CbGpPWpGaD
Estramustine—MAP2—nervous system—amyotrophic lateral sclerosis	0.00742	0.0184	CbGeAlD
Estramustine—MAP2—central nervous system—amyotrophic lateral sclerosis	0.00715	0.0177	CbGeAlD
Estramustine—MAP2—cerebellum—amyotrophic lateral sclerosis	0.00698	0.0173	CbGeAlD
Estramustine—ESR1—embryo—amyotrophic lateral sclerosis	0.00686	0.017	CbGeAlD
Estramustine—ESR2—Validated nuclear estrogen receptor beta network—C3—amyotrophic lateral sclerosis	0.00685	0.0266	CbGpPWpGaD
Estramustine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00662	0.0195	CcSEcCtD
Estramustine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00643	0.0189	CcSEcCtD
Estramustine—ESR1—brainstem—amyotrophic lateral sclerosis	0.00629	0.0156	CbGeAlD
Estramustine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00627	0.0185	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00625	0.0243	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00625	0.0243	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00625	0.0243	CbGpPWpGaD
Estramustine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00584	0.0172	CcSEcCtD
Estramustine—MAP2—brain—amyotrophic lateral sclerosis	0.00567	0.0141	CbGeAlD
Estramustine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00556	0.0164	CcSEcCtD
Estramustine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00554	0.0163	CcSEcCtD
Estramustine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00533	0.0157	CcSEcCtD
Estramustine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00521	0.0154	CcSEcCtD
Estramustine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00508	0.015	CcSEcCtD
Estramustine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00482	0.0142	CcSEcCtD
Estramustine—ESR2—nervous system—amyotrophic lateral sclerosis	0.00481	0.0119	CbGeAlD
Estramustine—ESR1—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.00476	0.0185	CbGpPWpGaD
Estramustine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00475	0.014	CcSEcCtD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—RAB5A—amyotrophic lateral sclerosis	0.00473	0.0184	CbGpPWpGaD
Estramustine—ESR2—central nervous system—amyotrophic lateral sclerosis	0.00463	0.0115	CbGeAlD
Estramustine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00463	0.0136	CcSEcCtD
Estramustine—ESR2—cerebellum—amyotrophic lateral sclerosis	0.00453	0.0112	CbGeAlD
Estramustine—ESR1—Integrated Breast Cancer Pathway—GRN—amyotrophic lateral sclerosis	0.00397	0.0154	CbGpPWpGaD
Estramustine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00377	0.0111	CcSEcCtD
Estramustine—ESR1—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.00376	0.0146	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00374	0.0145	CbGpPWpGaD
Estramustine—ESR1—Nuclear signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.00373	0.0145	CbGpPWpGaD
Estramustine—ESR2—brain—amyotrophic lateral sclerosis	0.00368	0.00912	CbGeAlD
Estramustine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00364	0.0107	CcSEcCtD
Estramustine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00998	CcSEcCtD
Estramustine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00989	CcSEcCtD
Estramustine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00335	0.00988	CcSEcCtD
Estramustine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00334	0.00983	CcSEcCtD
Estramustine—ESR1—nervous system—amyotrophic lateral sclerosis	0.00329	0.00817	CbGeAlD
Estramustine—ESR2—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.00324	0.0126	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00324	0.0126	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00318	0.0124	CbGpPWpGaD
Estramustine—ESR1—central nervous system—amyotrophic lateral sclerosis	0.00317	0.00787	CbGeAlD
Estramustine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00932	CcSEcCtD
Estramustine—ESR1—cerebellum—amyotrophic lateral sclerosis	0.0031	0.00769	CbGeAlD
Estramustine—ESR1—LKB1 signaling events—MAPT—amyotrophic lateral sclerosis	0.00297	0.0115	CbGpPWpGaD
Estramustine—MAP2—LKB1 signaling events—TP53—amyotrophic lateral sclerosis	0.00291	0.0113	CbGpPWpGaD
Estramustine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00275	0.0107	CbGpPWpGaD
Estramustine—ABCB1—embryo—amyotrophic lateral sclerosis	0.00271	0.00672	CbGeAlD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—SOD1—amyotrophic lateral sclerosis	0.00271	0.0105	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00259	0.0101	CbGpPWpGaD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—ATF1—amyotrophic lateral sclerosis	0.00259	0.0101	CbGpPWpGaD
Estramustine—ESR1—brain—amyotrophic lateral sclerosis	0.00252	0.00625	CbGeAlD
Estramustine—ESR2—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00245	0.00953	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00241	0.00936	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00241	0.00936	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00241	0.00936	CbGpPWpGaD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—IGF1—amyotrophic lateral sclerosis	0.00236	0.00916	CbGpPWpGaD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—C3—amyotrophic lateral sclerosis	0.00215	0.00834	CbGpPWpGaD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—amyotrophic lateral sclerosis	0.00198	0.00771	CbGpPWpGaD
Estramustine—ESR1—Nuclear signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.00194	0.00752	CbGpPWpGaD
Estramustine—ESR1—FOXA1 transcription factor network—SOD1—amyotrophic lateral sclerosis	0.00184	0.00716	CbGpPWpGaD
Estramustine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00184	0.00456	CbGeAlD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00178	0.00693	CbGpPWpGaD
Estramustine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00177	0.00439	CbGeAlD
Estramustine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.00173	0.0043	CbGeAlD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00173	0.00672	CbGpPWpGaD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—MMP9—amyotrophic lateral sclerosis	0.00172	0.00666	CbGpPWpGaD
Estramustine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.0017	0.00659	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.00163	0.00634	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00163	0.00633	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.00162	0.00628	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.0016	0.00623	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.00156	0.00605	CbGpPWpGaD
Estramustine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.00154	0.00383	CbGeAlD
Estramustine—MAP2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.00137	0.00533	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—SOD1—amyotrophic lateral sclerosis	0.00137	0.0053	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.00133	0.00515	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00131	0.00508	CbGpPWpGaD
Estramustine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.0013	0.00323	CbGeAlD
Estramustine—ESR2—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.00129	0.005	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00126	0.00489	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.00126	0.00488	CbGpPWpGaD
Estramustine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.00125	0.00311	CbGeAlD
Estramustine—ESR2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00125	0.00484	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00124	0.0048	CbGpPWpGaD
Estramustine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.00122	0.00304	CbGeAlD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—IGF1—amyotrophic lateral sclerosis	0.00119	0.00462	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00118	0.00459	CbGpPWpGaD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—amyotrophic lateral sclerosis	0.00112	0.00435	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—C3—amyotrophic lateral sclerosis	0.00108	0.0042	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00106	0.00412	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00101	0.00393	CbGpPWpGaD
Estramustine—ABCB1—brain—amyotrophic lateral sclerosis	0.000995	0.00247	CbGeAlD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.0009	0.00349	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000899	0.00349	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000873	0.00339	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—MMP9—amyotrophic lateral sclerosis	0.000865	0.00336	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000849	0.0033	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000821	0.00319	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000819	0.00318	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.000804	0.00312	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000786	0.00305	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000766	0.00297	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—CASP9—amyotrophic lateral sclerosis	0.000762	0.00296	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000761	0.00296	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000737	0.00286	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000708	0.00275	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000692	0.00269	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000689	0.00267	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.00068	0.00264	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000668	0.0026	CbGpPWpGaD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	0.000666	0.00259	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.000652	0.00253	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.00065	0.00252	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000635	0.00246	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000623	0.00242	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—RARA—amyotrophic lateral sclerosis	0.00062	0.00241	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000596	0.00231	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000571	0.00222	CbGpPWpGaD
Estramustine—ESR1—LKB1 signaling events—TP53—amyotrophic lateral sclerosis	0.000565	0.00219	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—MMP9—amyotrophic lateral sclerosis	0.000564	0.00219	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000548	0.00213	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000535	0.00208	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00053	0.00206	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000529	0.00205	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000511	0.00198	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000484	0.00188	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000476	0.00185	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000462	0.00179	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.00045	0.00175	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00044	0.00171	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000435	0.00169	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000413	0.0016	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000396	0.00154	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000384	0.00149	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TP53—amyotrophic lateral sclerosis	0.000383	0.00149	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000372	0.00144	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000347	0.00135	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.00034	0.00132	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000336	0.0013	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000323	0.00125	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000313	0.00122	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000288	0.00112	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000287	0.00111	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000283	0.0011	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000281	0.00109	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000274	0.00106	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00027	0.00105	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000267	0.00104	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000255	0.000992	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000245	0.000952	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000245	0.000952	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.000243	0.000944	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000227	0.000881	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000224	0.00087	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000217	0.000844	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000217	0.000844	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000212	0.000824	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000208	0.000809	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000207	0.000803	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000199	0.000775	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000197	0.000765	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000196	0.000761	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000194	0.000755	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000194	0.000752	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000189	0.000734	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000184	0.000713	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000183	0.000711	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000177	0.000688	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000171	0.000666	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000163	0.000632	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000161	0.000624	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000152	0.000592	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000151	0.000586	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000151	0.000586	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000141	0.000549	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000138	0.000536	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000134	0.000521	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000128	0.000498	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000124	0.000481	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000121	0.000469	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.00012	0.000466	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00011	0.000429	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000109	0.000424	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000104	0.000402	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000102	0.000395	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.87e-05	0.000383	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	9.07e-05	0.000352	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.45e-05	0.000328	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	8.27e-05	0.000321	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.94e-05	0.000308	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	7.63e-05	0.000296	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.02e-05	0.000273	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.53e-05	0.000254	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	6.27e-05	0.000243	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.47e-05	0.000212	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.4e-05	0.00021	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.03e-05	0.000195	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.16e-05	0.000161	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	4.13e-05	0.000161	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.93e-05	0.000153	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.53e-05	0.000137	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.37e-05	0.000131	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.1e-05	0.00012	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.83e-05	0.00011	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.66e-05	0.000103	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.55e-05	9.89e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.75e-05	6.78e-05	CbGpPWpGaD
